Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Strategic Asset Allocation Index
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Strategic Asset Allocation Index of 15.1% as of September 2023. Strategic assets (PP&E of CN¥688.38 Million plus long-term investments of CN¥-) total CN¥688.38 Million, measured against net assets of CN¥4.56 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Guangdong Zhongsheng Pharmaceutical Co Ltd Strategic Asset Allocation Index (2009–2021)
This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2009 to 2021. As of September 2023, the index stands at 15.1%, representing strategic assets of CN¥688.38 Million against net assets of CN¥4.56 Billion CNY. Explore 002317 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Guangdong Zhongsheng Pharmaceutical Co Ltd (2009–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2009 to 2021, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Guangdong Zhongsheng Pharmaceutical Co L.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 17.0% | CN¥601.24 Million | CN¥601.24 Million | CN¥- | CN¥3.54 Billion | ▲ +1.6 pp |
| 2020 | 15.4% | CN¥557.97 Million | CN¥557.97 Million | CN¥- | CN¥3.63 Billion | ▲ +0.3 pp |
| 2019 | 15.1% | CN¥623.55 Million | CN¥623.55 Million | CN¥- | CN¥4.13 Billion | ▼ -4.9 pp |
| 2018 | 20.0% | CN¥789.01 Million | CN¥657.69 Million | CN¥131.33 Million | CN¥3.95 Billion | ▲ +5.5 pp |
| 2017 | 14.4% | CN¥538.05 Million | CN¥490.03 Million | CN¥48.03 Million | CN¥3.73 Billion | ▼ -1.1 pp |
| 2016 | 15.5% | CN¥531.07 Million | CN¥506.34 Million | CN¥24.74 Million | CN¥3.42 Billion | ▼ -12.4 pp |
| 2015 | 27.9% | CN¥589.07 Million | CN¥579.07 Million | CN¥10.00 Million | CN¥2.11 Billion | ▲ +2.1 pp |
| 2014 | 25.9% | CN¥491.20 Million | CN¥491.20 Million | CN¥- | CN¥1.90 Billion | ▼ -4.5 pp |
| 2013 | 30.3% | CN¥528.81 Million | CN¥528.81 Million | CN¥- | CN¥1.74 Billion | ▲ +5.7 pp |
| 2012 | 24.7% | CN¥391.21 Million | CN¥391.21 Million | CN¥- | CN¥1.59 Billion | ▲ +0.2 pp |
| 2011 | 24.4% | CN¥361.06 Million | CN¥361.06 Million | CN¥- | CN¥1.48 Billion | ▲ +10.2 pp |
| 2010 | 14.3% | CN¥198.07 Million | CN¥198.07 Million | CN¥- | CN¥1.39 Billion | ▲ +2.9 pp |
| 2009 | 11.3% | CN¥146.96 Million | CN¥146.96 Million | CN¥- | CN¥1.30 Billion | — |